A statistically significant association exists between efavirenz for initial HIV therapy and the risk suicidality. When this drug is given as a component of an antiretroviral drug regimen, patients should be monitored carefully for the possibility of deterioration of their depression or evidence of suicidal behavior.
The FDA today announced that it is preparing to regulate laboratory tests developed and marketed within a single lab. This should lead eventually to more clarity about testing for diagnosis and treatment of rheumatic diseases.
Persons with epilepsy have a higher prevalence of comorbid conditions -- psychiatric disorders in particular -- than the general population. Here: a look at the most common comorbidities and a discussion of the clinical implications.